Resources

This fact sheet describes PATH’s work to develop a vaccine against Group B Streptococcus. It details current prevention methods, global disease burden, and the maternal immunization strategy. It also describes PATH’s vaccine development partnership with Inventprise Inc. in Redmond, WA, USA.

Standard Operating Procedure:The Trinity Glucose-6 Phosphate Dehydrogenase Fluorescent Spot Screening test isused for the qualitative, visual fluorescence screening of G6PD activity in human bloodsamples.

PATH is collaborating with the Novartis Foundation to introduce an innovative healthcare delivery model designed to improve hypertension management and control in Vietnam. The project aims to improve blood pressure control among adults by increasing access to and use of high-quality hypertension services that are sustainable and scalable.

The Data Use Partnership (DUP) helped the Government of Tanzania identify a set of digital health investment recommendations with the highest potential value and alignment to national priorities. This report examines the unique factors of success in the development of Tanzania's Digital Health Investment Road Map. Included here is the full white paper, executive summary, and infographic examining this partnership and factors of success.